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Abstract 
 
Background: Colonization of nasopharynx by Streptococcus pneumoniae can lead to pneumococcal diseases. 
This  study  was  performed  to  determine  the  carriage  rate of  nasopharyngeal  S.  pneumoniae  in  adolescents, 
antibiotic susceptibility and serotype prevalence in Zahedan, Iran. 
 
Methods:  Nasopharyngeal  specimens  from  865  adolescents  (age  range:  10-19  years  old)  attending  eight 
schools in Zahedan, Iran, were collected and assessed by standard procedures to recover S. pneumoniae. The 
serotyping was carried out by latex agglutination test and the minimum inhibitory concentrations (MIC) of penicil-
lin as well as other commonly used antibiotics were determined by a broth dilution method.  
 
Results: Pneumococci were recovered from 15.7% (136/865, 95% confidence interval (CI) 12.3-18.9) of total 
samples which 119 isolates were typable with the available antisera. 1, 19A, 15C, 9V, 11A and 19F were found 
as the most frequent serotypes. Ninety three pneumococcal isolates were sensitive to penicillin. The MIC values 
of antibiotics tested were (µg/ml): penicillin 0.01-4, cefotaxime 0.01-4, ceftriaxone 0.02-128, chloramphenicol 
0.08-32, ciprofloxacin 0.06-16, erythromycin 0.01-128, tetracycline 0.08-128 and vancomycin 0.02-1.  
 
Conclusion: A clear diversity was seen in the serotype distribution of the S. pneumoniae isolates and most of 
the antibiotic resistant strains belonged to few serotypes. Healthy adolescents in Zahedan, Iran commonly show 
pneumococcal carriage and antibiotic resistance. 
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Introduction 
 
In  community-acquired  respiratory  tract  infections, 
Streptococcus pneumoniae is the most commonly iso-
lated pathogen and it causes a variety of infections like 
pneumonia, acute otitis media and sinusitis.
1 Coloniza-
tion of nasopharynx can lead to pneumococcal disease 
and hence is a potential source of horizontal spread in 
the community, especially in conditions of high crowd-
ing index. The highest worldwide nasopharyngeal col-
onization rates were reported from Africa (85-87.2%).
2 
Even if  nasopharyngeal isolates do not play important 
role in identifying the invasive disease causing agent in 
individuals,  analysis  of  the  dominant  serotypes  in  a 
certain  region  reveal  epidemiological  importance  of 
pneumococcal disease in the community.
3 
Distribution of invasive disease causing serotypes, 
colonization of nasopharynx and resistance to antibi-
otics could be related to age, geography, and socio-
economic conditions of that population.
4-7 As the se-
verity of the disease in this population is less, naso-
pharyngeal carriage and serotype distribution in ado-
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lescents have not been studied in detail. A few studies 
revealed  pharyngeal  S.  pneumoniae  carriage  in 
healthy Iranian children, but pneumococcal nasopha-
ryngeal carriage prevalence, its resistance to antibiot-
ics  and  serotype  distribution  in  adolescents  are  un-
known. To initiate an adequate empirical antibacterial 
therapy, understanding of nasopharyngeal carriage of 
resistant  Pneumococci  and  serotype  distribution  is 
essential. Thus we carried out this research to investi-
gate and determine the nasopharyngeal carriage rates, 
serotype  prevalence  and  in  vitro  antimicrobial  re-
sistance of this pathogen isolated from healthy ado-
lescents in Zahedan, Iran.   
 
 
Materials and Methods 
 
In this cross-sectional study, 865 healthy adolescents 
(aged between 10 and 19 years old: 435 females and 
430 males) attending eight public schools in Zahedan, 
South-Eastern Iran, were registered as study samples 
from April 2007 to February 2008. Sample size was 
calculated  using  the  formula  N=Zα
2×P(1-P)/d
2
  for 
prevalence surveys with an expected proportion of p 
at 10%, an alpha of 0.05, and a level of precision (d) 
of 0.02. Our study protocol was approved by the Eth-
ics Committee and the Research Council (ECRC) of 
the Zahedan University of Medical Sciences (ZUMS).  
Nasopharyngeal samples were collected by using 
calcium alginate swabs and were plated immediately 
onto  tryptic  soy  agar  plates  containing  5%  sheep 
blood and 5 µg gentamicin ml
-1. Plates were incubat-
ed  at  37˚C  in  5%  CO2  for  48  h.  Alpha-hemolysis, 
optochin  sensitivity,  and  bile  solubility  tests  were 
employed to identify S. pneumoniae isolates. Pneu-
mococcal isolates were grown in Todd-Hewitt broth 
plus 0.5% yeast extract and stored in 20% glycerol at 
-80˚C  simultaneously  the  antibiotic  susceptibility 
screening and serotype determination were carried out. 
Pneumococcal serogroups and serotypes were de-
termined by latex agglutination test and the Quellung 
reaction  method  using  the  polyclonal  rabbit  antisera 
and selected factor sera (Pneumotest-Latex kit; Statens 
Serum Institute, Copenhagen, Denmark) respectively. 
Kirby-Bauer  disk  diffusion  method  as  recom-
mended by the National Committee for Clinical La-
boratory Standards (NCCLS) M2-A6 guidelines were 
used to determine antimicrobial susceptibility of oxa-
cillin (1 µg).
 After 24 h of incubation at 35˚C, in the 
presence of 5% CO2, the diameter of the zone of inhi-
bition  was  measured. The  inhibition  zones  of ≥ 20 
and  ≤19  mm  were  considered  penicillin-susceptible 
and penicillin-resistant respectively.
  
Micro  broth  dilution  method
  using  below  given 
concentrations of antibiotics (µg/ml) was used in or-
der to determine the MICs of antimicrobial agents: 
penicillin (0.015-16), cefotaxime (0.015-8), ceftriax-
one  (0.02-128),  chloramphenicol  (1-64),  ciprofloxa-
cin (0.125-32), erythromycin (0.06-128), tetracycline 
(0.25-128) and vancomycin (0.5-8).
 Micro broth dilu-
tion method as recommended by the National Com-
mittee  for  Clinical  Laboratory  Standards  (NCCLS) 
M7-A3 guidelines was used to determine the MICs of 
antimicrobial agents.
 A turbidity equivalent of  0.5% 
McFarland standard in 0.9% saline was prepared by 
suspending  growth  obtained  from  5%  sheep  blood 
agar  plates  and  diluted  1:10  to  give  10
7  CFU/ml. 
Mueller-Hinton  broth  supplemented  with  5%  lysed 
horse blood containing a series of increasing concen-
trations of antimicrobial agents was inoculated by this 
dilution. The test tubes were incubated at 35˚C for 20 
to  24  h  and  the  lowest  concentration  of  antibiotics 
which  inhibited  the  visible  growth  of  bacteria  was 
considered  as  MIC.  We  used  a  penicillin-resistant 
strain of S. pneumoniae ATCC 49619 with a MIC of 
0.25-0.5 µg/ml as control strain. 
Analyses  by  the  Chi-Square  and  Fisher’s  Exact 
tests were performed in SPSS (Version 14.0 for Win-
dows,  Chicago,  IL,  USA).  P  values  of  <0.05  were 
considered significant.  
 
 
Results 
 
Out  of  the  total  865  adolescents  (age  range  10-19 
years, mean 14.7±2.1), Pneumococcus was recovered 
from 136 samples (15.7%, 95% CI 12.3-18.9) and the 
pneumococcal  colonization  rate  decreased  with  age 
(Table 1). 87.5% (119) of total isolates (136) were 
serotyped with the available antisera (Table 2). It was 
found that serotypes 1 (n=14), 19A (n=12) and 15C 
(n=11)  were  more  prevalent  than  9V  (n=10),  11A 
(n=10), and 19F (n=9) serotypes (Table 2). No signifi-
cant statistical difference was seen for the serotypes 
and age and sex (p>0.05). Because of cross reactions 
with more than one antisera and non availability of the 
antisera, 17 isolates (12.5%) could not be serotyped. 
Of  the  136  S.  pneumoniae  isolates,  93  (68.5%) 
were  penicillin-sensitive  while  the  remaining  43 
(31.5%)  were  penicillin-nonsusceptible  (30  isolates, 
22.0%,  intermediately  resistant  and  13,  9.5%,  fully 
resistant).  The  most  of  penicillin-resistant  isolates Bokaeian et al. 
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belonged to serotypes 19A, 9V, 11A, and 23F. Table 3 
shows  the  summary  of  the  activities  of  tested  
antibiotics  against  the  136  nasopharyngeal  isolates 
categorized by penicillin susceptibility. Based on our 
findings, penicillin-resistant isolates of S. pneumoniae 
were more likely to be resistant to other antibiotics 
whereas penicillin-susceptible isolates were suscepti-
ble to other tested antibiotics. 18.3% of all isolates 
showed full resistances to erythromycin, 9.5% to tet-
racycline, 9.5% to penicillin, 8.0% to chlorampheni-
col,  3.6%  to  ceftriaxone,  2.2%  to  cefotaxime,  and 
1.4% to ciprofloxacin successively. No any isolates 
showed resistance to vancomycin. Of the 13 isolates 
that  were  highly  resistant  to  penicillin,  11  (84.5%) 
also had decreased sensitivity to chloramphenicol, 10 
(76.8%) to erythromycin, 8 (61.4%) to ciprofloxacin, 
7 (53.7%) to cefotaxime, 6 (46.0%) to tetracycline, 
and  4  (30.6%)  to  ceftriaxone  successively.  A  good 
agreement was seen between penicillin MIC findings 
and oxacillin disk diffusion inhibition zone size. 
Serotyping was available for 50 strains (86.2% of 
resistant strains) out of 58 pneumococcal strains that 
showed moderate or full resistance to at least one an-
tibiotic class. 75.2% of the total number of resistant 
strains consisted of 19A, 9V, 11A and 23F serotypes. 
 
 
Discussion 
 
On  the  whole  nasopharyngeal  carriage  rate  of  S. 
pneumoniae in healthy adolescents in the present re-
search  was  15.7%.  Pneumococcal  nasopharyngeal 
carriage studies were mostly done only on children.
8 
A few studies were carried on adolescents along with 
children or the whole population showing prevalence 
of pneumococcal carriage from 19 to 43%.
1,9,10 How-
ever, these investigations do not provide proper eval-
uation of adolescents.  
In this study, the overall prevalence of penicillin 
full resistance (8.9%, MIC= 2 µg/ml) and penicillin 
intermediate  resistance  (22.2%, MIC=0.12-1  µg/ml) 
is similar to values reported worldwide ranging from 
1.4 to 71%.
11 There is no sufficient information re-
garding antimicrobial resistance patterns of nasopha-
ryngeal S. pneumoniae strains in healthy adolescents 
in Iran. The overall prevalence of penicillin resistant 
S. pneumoniae has been reported as 15.6% in a study 
carried out in Shiraz, Iran.
12 The rates of pneumococ-
cal colonization and penicillin resistance varied great-
ly within regions and continents.
2  
In our study, both penicillin-resistant (38.4%) and 
penicillin-susceptible  strains  (5.3%)  showed  re-
sistance to erythromycin that was similar to reports 
from other Asian countries.
13 For treatments of res-
piratory tract infections, macrolides are used as alter-
native  of  β-lactams.  However  lately  conducted sur-
veillance study data revealed an increase in the preva-
lence  of  macrolide-resistant  S.  pneumoniae  in  Iran 
and many parts of the world.
12,14 Erythromycin gener-
ally  suggested  as  an  alternative  oral  therapy  for 
pneumococcal infection and penicillin-sensitive indi-
Table  1:  Prevalence  of  nasopharyngeal  pneumo-
coccal  colonization  among  adolescents  by  age  in 
years (The χ
2 value for the trend is 7.34, p=0.04). 
Age (years)  No./total  Percentage  
(95% CI) 
10  9/35   25.7 (20.7-28.3) 
11  12/47   25.5 (19.1-27.8) 
12   16/78   20.5(17.7-22.9) 
13  19/106   17.9 (15.5-19.8) 
14  19/118   16.1 (12.6-18.4) 
15  21/124   16.9 (13.1-19.6) 
16  15/136   11.0 (8.7-14.4) 
17  12/110   10.9 (7.2-15.8) 
18  7/62   11.2 (9.5-14.3) 
19  6/49   12.2 (11.1-16.7) 
Total  136/865   15.7 (12.3-18.9) 
 
 
Table  2:  Distribution  of  serotypes  of  S.  pneumoniae 
strains among adolescents. The serotypes are ranked 
in their order of frequency. 
Serotype  No. of strains  % 
1 
19A 
14  
12  
10.29 
8.82 
15C 
 9V 
11A 
19F 
23F 
23A 
6B 
3 
13 
35B 
20 
18C 
10A 
37 
29 
41 
Non-typable  
11  
10  
10  
9  
8  
8  
7  
6  
5  
5  
4  
3  
3  
2  
1  
1  
17  
8.08 
7.35 
7.35 
6.61 
5.88 
5.88 
5.14 
4.41 
3.67 
3.67 
2.94 
2.20 
2.20 
1.47 
0.73 
0.73 
12.49 
Total  136   100 
 Pneumococcal carriage and resistance 
 
WWW.ircmj.com Vol 13 May 2011  331 
viduals. However, our results do not recommend this 
suggestion,  since  38.4%  of  penicillin  resistant  S. 
pneumoniae  isolates  were  also  non-susceptible  to 
erythromycin.  Excessive  consumption,  inappropriate 
and overdose use of erythromycin and other macro-
lides for treatment of pneumococcal infections may 
be  the  major  contributory  factors  for  the  elevated 
prevalence of macrolide resistance in our country and 
elsewhere. 
It  is  found  in  our  study  of  43  penicillin-non-
susceptible  isolates,  41.8%  and  30.2%  were  non-
susceptible to cefotaxime and ceftriaxone respective-
ly.  The  broad-spectrum  cephalosporins  have  been 
suggested for treatment of pneumococcal infections, 
but the patients with pneumococcal meningitis from 
the USA and Spain did not respond at all.
15 An in-
crease in the MIC of ceftriaxone and cefotaxime against 
penicillin-resistant S. pneumoniae is believed to be the 
cause of this incompetence. Ceftriaxone and cefotaxime 
are considered as alternatives in treating infections with 
penicillin-resistant S. pneumoniae, still their resistance 
to these antibiotics reveals a sign of alert. 
Nasopharyngeal isolates showed high resistance to 
tetracycline and chloramphenicol. This resistance is pos-
sibly due to dose convenience, cost-effectiveness, easy 
availability over the counter and wider use of these anti-
biotics in the hospital as well as the community.  
Eighteen multidrug resistant S. pneumoniae were 
isolated in our study. Resistance to penicillin and two 
or more non β-lactam agents such as macrolides, co-
trimoxazole or tetracycline is considered as multidrug 
resistance. Multidrug  resistant  S.  pneumoniae is in-
creasingly  being  reported  from  many  parts  of  the 
globe.
16 The presence or absence of a multidrug re-
sistant phenotype can be marked by penicillin suscep-
tibility. Strains with reduced susceptibility to penicil-
lin usually show cross-resistance to other antibiotics 
and  such  cross-resistance was  observed  with  eryth-
romycin,  tetracycline,  chloramphenicol  and  ciprof-
loxacin.  More  than  75%  of  the  antibiotic  resistant 
strains in our study belonged to four serotypes. Katsa-
rolis et al. and Dobay et al. reports revealed similar 
results.
17,18 
The increasing penicillin and multidrug resistance 
of S. pneumoniae bear worldwide important clinical 
implications. Reduced pneumococcal susceptibility in 
Iran may be caused by excessive antibiotic consump-
tion and in some cases without medical prescription. 
The  progress  of  pneumococcal  antibiotic  resistance 
over the last two decades has stirred up a global con-
cern, an evolution generally related to an extensive 
consumption  of  antibiotics.
19,20  The  surveillance  of 
alteration  in  antibiotic  susceptibilities  due  to  time 
Table 3: Sensitivity of nasopharyngeal isolates of S. pneumoniae from adolescents. 
Antibiotic  Total number of 
cases 
(n=136) 
Penicillin sensitivity  MIC 
rang 
µg/ml 
Sensitive (n=93)   Intermediate (n=30)  Resistant (n=13) 
S
b  I
c  R
d  S  I  R  S  I  R  S  I  R 
Penicillin
e  93
a 
(68.5) 
30 
(22.0) 
13 
(9.5) 
                  <0.03-4 
Cefotaxime
f  107 
(78.6) 
26 
(19.1) 
3 
(2.3) 
90 
(96.8) 
2 
(2.2) 
1 
(1) 
18 
(59.9) 
8 
(26.7) 
4 
(13.4) 
6 
(46.0) 
4 
(31.0) 
3 
(23.0) 
0.03-4 
Ceftriaxone
g  118 
(86.7) 
13 
(9.6) 
5 
(3.7) 
87 
(93.5) 
6 
(6.5) 
0 
(0) 
20 
(66.6) 
9 
(30.0) 
1 
(3.4) 
9 
(69.0) 
1 
(8.0) 
3 
(23.0) 
<0.02-
128 
Chloram-
phenicol
h 
81 
(59.5) 
44 
(32.4) 
11 
(8.1) 
85 
(91.4) 
7 
(7.6) 
1 
(1) 
12 
(40.0) 
12 
(40.0) 
6 
(20.0) 
2 
(15.5) 
4 
(31.0) 
7 
(53.5) 
<0.08-
32 
Ciprofloxacin
i  115 
(84.6) 
19 
(13.9) 
2 
(1.5) 
85 
(91.3) 
5 
(5.4) 
3 
(3.3) 
10 
(33.3) 
13 
(43.3) 
7 
(23.4) 
5 
(38.0) 
4 
(31.0) 
4 
(31.0) 
0.06-16 
Erythromycin
j  83 
(61.0) 
28 
(20.6) 
25 
(18.4) 
82 
(88.1) 
6 
(6.5) 
5 
(5.4) 
12 
(40.0) 
9 
(30.0) 
9 
(30.0) 
3 
(23.0) 
5 
(38.0) 
5 
(38.0) 
<0.01-
128 
Tetracycline
k  87 
(63.9) 
36 
(26.5) 
13 
(9.6) 
71 
(76.3) 
15 
(16.1) 
7 
(7.6) 
11 
(36.6) 
14 
(46.7) 
5 
(16.7) 
7 
(54.0) 
3 
(23.0) 
3 
(23.0) 
<0.08-
128 
Vancomycin
l  136 
(100) 
0 
(0) 
0 
(0) 
93 
(100) 
0 
(0) 
0 
(0) 
30 
(100) 
0 
(0) 
0 
(0) 
13 
(100) 
0 
(0) 
0 
(0) 
<0.02-1 
a Figures in parentheses are percentages, 
b S=sensitive, 
c I=intermediate, 
d R=resistant. Break point of antibiotics 
(μg/ml), 
e penicillin=0.1, 
f cefotaxime=32, 
g ceftriaxone=30, 
h chloramphenicol=16, 
I ciprofloxacin=5, 
j erythromycin=4, 
ktet-
racycline=8, 
l vancomycin=16. Bokaeian et al. 
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plays an important role in recognizing the potential 
hazards associated with S. pneumoniae infections. 
In our study, most frequent serotypes were 1, 19A, 
15C, 9V, 11A, and 19F in healthy adolescents. These 
serotypes are commonly involved in invasive pneu-
mococcal  diseases,  highlighting  the  importance  of 
nasopharyneal  colonization  in  the  development  of 
serious  community  infections.  There  is  no  infor-
mation  on  the  nasopharyngeal  carriage  of  S.  pneu-
moniae  and  serotype  distribution  in  healthy  adoles-
cents in Iran. In a study done by Cardozo et al. in 
Brazilian  adolescents,  it  was  revealed  that  6B,  6A, 
23F and 18C were the most common nasopharyngeal 
serotypes.
5  In  another  study  done  by  Nascimento-
Carvalho et al. in Salvador, it has been reported 14, 5, 
6A, 6B, 19F, 9V, 18C and 23F as the most common 
serotypes.
21 In Greece on the other hand, 19F, 14, 23F 
and  6B  serotypes  have  been  reported  as  the  most 
common pneumococcal serotypes.
22 
Considering the above findings, we can conclude 
that pneumococcal carriage and antibiotic resistance 
is  common  among  healthy  adolescents  in  Zahedan, 
Iran. A clear diversity was seen among the serotype 
distribution of the isolates and most of the S. pneu-
moniae  isolates  circulating  in  the  population  were 
invasive. Data obtained in this article and related pub-
lications  emphasize  the  hasty  need  to  control  the 
proper  use  of  antibiotics  to  decrease  the  antibiotic 
resistant S. pneumoniae among adolescents.  
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